Home › Funds › PRELUDE CAPITAL MANAGEMENT, LLC › ETON

PRELUDE CAPITAL MANAGEMENT, LLC position in ETON

ETON PHARMACEUTICALS INC COM · Health Care

PRELUDE CAPITAL MANAGEMENT, LLC reported holding 137,572 shares of ETON (ETON PHARMACEUTICALS INC COM) in its Q2 2026 13F filing — a position valued at US$5.0M, representing 0.40% of its reported portfolio and ranking #47 among its reported holdings. PRELUDE CAPITAL MANAGEMENT, LLC has disclosed ETON holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)137.57K sh
Reported value held$4.98M
Portfolio Weight0.40%
First reportedQ4 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PRELUDE CAPITAL MANAGEMENT, LLC's ETON position evolved

PRELUDE CAPITAL MANAGEMENT, LLC first disclosed a stake in ETON in Q4 2024 at 24,242 shares (US$323K). The position peaked in Q2 2026 at 137,572 shares, worth US$5.0M. Across 7 filings, PRELUDE CAPITAL MANAGEMENT, LLC increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 137,572 shares valued at US$5.0M — a reduction of -51,230 shares quarter over quarter.. Notable position changes include a 599% increase in Q1 2025 (shares rose 10% over the following quarter), a 74% trim in Q2 2025 (shares rose 52% over the following quarter), a 317% increase in Q1 2026 (shares rose 47% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 24.24K $322.90K New
Q1 2025 169.44K $2.20M Add
Q2 2025 43.60K $621.30K Reduce
Q3 2025 41.87K $909.90K Reduce
Q4 2025 45.33K $766.45K Add
Q1 2026 188.80K $4.66M Add
Q2 2026 137.57K $4.98M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ETON and 13F data

ETON (ETON PHARMACEUTICALS INC COM) is a Health Care company. 64 other funds we track also report a position in ETON — the largest reported positions include Opaleye Management Inc. (US$103.5M), EcoR1 Capital, LLC (US$78.6M), Nantahala Capital Management, LLC (US$42.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ETON

All ETON fund holders →

FAQ

How long has PRELUDE CAPITAL MANAGEMENT, LLC held ETON?

PRELUDE CAPITAL MANAGEMENT, LLC has disclosed ETON holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is PRELUDE CAPITAL MANAGEMENT, LLC's current position in ETON?

As of Q2 2026, PRELUDE CAPITAL MANAGEMENT, LLC holds 137.57K shares of ETON (ETON PHARMACEUTICALS INC COM), valued at $4.98M, representing 0.40% of its reported portfolio and ranking #47.

Has PRELUDE CAPITAL MANAGEMENT, LLC been buying or selling ETON?

In the latest 13F filing (Q2 2026), PRELUDE CAPITAL MANAGEMENT, LLC reduced its position in ETON. The position peaked in Q2 2026 at 137.57K shares.

Which other funds hold ETON?

Other major institutional holders of ETON include Opaleye Management Inc., EcoR1 Capital, LLC, Nantahala Capital Management, LLC, among 64 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.